Medicare plan "a success;" ex-HHSS

2 April 2006

With more than 27.5 million seniors and people with disabilities enrolled in the US Medicare's prescription drug benefit to date, former Health and Human Services Secretary Tommy Thompson has discussed the growing success of the new drug benefit during the American Autoimmune Related Diseases Association's National Autoimmune Diseases Conference.

"The enrollment of 380,000 people per week into Medicare prescription drug coverage is encouraging because we know that seniors and people with disabilities are receiving coverage that increases their access to medicines and reduces their health care costs," he said.

Recent enrollment figures show that more than 60% of the estimated 42 million Americans eligible for the new Medicare Part D drug benefit have prescription drug coverage. "The success of the new Medicare prescription drug benefit is evident every time one of the more than 27.5 million enrolled beneficiaries steps into a pharmacy and receives their medicines," said Thompson. "It is important to acknowledge those who have enrolled in Medicare drug coverage so other beneficiaries will realize that the benefit is there for them and seriously consider what this new coverage means to them." he added.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight